Vancomycin Pretreatment Attenuates Acetaminophen-Induced Liver Injury Through 2-Hydroxybutyric Acid

Ningning Zheng,Yu Gu,Ying Hong,Lili Sheng,Linlin Chen,Feng Zhang,Jie Hou,Weidong Zhang,Zean Zhang,Wei Jia,Houkai Li

DOI: https://doi.org/10.1016/j.jpha.2019.11.003

2020-01-01

Abstract:Liver injury caused by acetaminophen（AP） overdose is a leading public health problem. Although APinduced liver injury is well recognized as the formation of N-acetyl-p-benzoquinone（NAPQI）, a toxic metabolite of AP, resulting in cell damage, emerging evidence indicates that AP-induced liver injury is also associated with gut microbiota. However, the gut microbiota-involved mechanism remains largely unknown. In our study, we found that vancomycin（Vac） pretreatment（100 mg/kg, twice a day for 4 days） attenuated AP-induced liver injury, altered the composition of gut microbiota, and changed serum metabolic profile. Moreover, we identified Vac pretreatment elevated cecum and serum 2-hydroxybutyric acid（2-HB）, which ameliorated AP-induced cell damage and liver injury in mice by reducing AP bioavailability and elevating GSH levels. Our current results revealed the novel role of 2-HB in protecting AP-induced liver injury and add new evidence for gut microbiota in affecting AP toxicity.